The question is never ‘should we use AI.’ It is ‘what job needs doing, and does this tool do it better than our current approach?’ This Field Note gives you a durable evaluation framework that applies to AI today and to whatever comes next.
AI is not the first technology to arrive with transformative claims and require careful evaluation. The same framework that should have been applied to marketing automation, ABM platforms, and intent data tools applies here. Most companies skip the framework and pay for it twice: once in adoption cost, once in reversal cost.
Every new marketing technology arrives with claims that are partially true at best. The companies that adopt early and uncritically waste budget and time. The companies that dismiss entirely miss genuine efficiency gains. The right question is never "should we use AI" but "which specific job does this tool do, and is that job blocking our growth?"
AI is not categorically different from any other technology in how you should evaluate it. The evaluation framework is the same: does it do a job that needs doing, does it do that job better than the current approach, and does the improvement justify the cost of adoption and integration? The difference is scale and speed of capability change — not the decision logic.
Most Indian B2B companies don't have large marketing teams. The technology evaluation question is really: does this tool give a small team the output of a larger one — without requiring the team to spend as much time managing the tool as they would doing the work manually? That constraint changes which tools are worth adopting.
In B2B marketing, credibility is a primary asset. Any technology that scales the production of generic, detectable output damages credibility faster than it builds pipeline. This is the specific risk that AI creates in B2B contexts that it does not create in B2C — and it is the first question to ask before adopting any AI tool in a B2B marketing stack.
L1 questions ask which tools to use. L2 questions ask what job needs doing — and whether any tool actually does it.
These steps apply to any technology, with specific applications to AI at each stage. The framework is durable because it is built on evaluation logic, not on the current capabilities of any specific tool.
Start with the bottleneck, not the technology
Technology evaluation should begin with your biggest marketing bottleneck, not with a tool you heard about. The question is not 'what can AI do for us' but 'what is slowing us down most — and is there a tool that fixes it?'
Most marketing teams evaluate technology the wrong way round: they see a tool, find a use case for it, and justify the adoption. The right order is: identify the bottleneck, define what a solution to it looks like, then evaluate tools against that definition. This inversion eliminates most of the tools you would otherwise consider.
Apply the six evaluation questions before adopting any tool
The evaluation framework is the same for AI as it is for any marketing technology. The six questions below have stayed consistent across every technology wave — CRM, marketing automation, ABM platforms, and now AI. Apply them every time.
Specific AI tools will change significantly over the next 12-24 months. The evaluation framework will not. Building the habit of applying these six questions before any tool adoption produces better decisions than following any list of recommended tools.
For B2B SaaS, the highest-value AI applications are in research and signal processing rather than content generation. AI tools that process intent signals from G2 reviews, job postings, and technographic data to identify accounts showing buying intent consistently produce better pipeline than AI tools that generate blog content. AI-assisted meeting transcription and CRM data enrichment reduce administrative burden without credibility risk. AI content generation requires heavy editorial oversight — the output is rarely specific enough for a sophisticated B2B buyer without significant human refinement.
IT services companies that use AI to generate thought leadership content face a specific credibility risk: the CIO and analyst audience they are trying to reach are sophisticated enough to recognise generic AI output. A single detectable AI-generated article in a campaign targeting Gartner analysts or CIO forums can damage the credibility that takes years to build. Keep AI out of thought leadership content entirely. Use it for internal research, proposal drafting, and competitive intelligence instead.
Manufacturing marketing content — datasheets, application notes, technical specifications — requires domain accuracy that current AI tools cannot reliably provide without expert review. Any error in a technical specification document that reaches a procurement engineer can disqualify the vendor immediately. AI is valuable for manufacturing marketing in non-technical areas: quote generation from structured data, RFQ response drafting from templates, and competitive monitoring of trade publications. Not for technical content that requires engineering validation.
Pharma B2B marketing content that could be construed as promotional requires medical affairs review regardless of how it was produced. AI-generated clinical or scientific content that bypasses this review creates regulatory risk that no efficiency gain justifies. The highest-value AI applications in pharma marketing are in areas that don't touch promotional content: literature monitoring, conference research, KOL mapping, and internal document summarisation. These produce genuine time savings with minimal risk.
For BFSI, logistics, and relationship-driven B2B categories, the highest-value AI application is account research before high-stakes conversations. AI tools that synthesise a target company's recent news, leadership changes, financial results, and industry context — producing a briefing document in minutes that would take hours manually — give sales teams a genuine advantage in the conversation quality that drives enterprise deals. This application is low-risk, high-impact, and immediately measurable.
Separate high-credibility-risk from low-credibility-risk applications
In B2B, the most important dimension of any AI application is its credibility risk. Tools that produce detectable generic output in buyer-facing contexts damage the thing B2B marketing is ultimately trying to build: trust. Separate applications by this dimension before evaluating anything else.
| AI application | Credibility risk | Efficiency gain | Recommended approach |
|---|---|---|---|
| Blog and long-form content generation | High — detectable by sophisticated buyers | Medium | Use AI for research and outlines; human writes and edits final copy |
| Email subject line testing | Low | High | Adopt freely; test and iterate quickly |
| Lead intent signal processing | Low | Very high | Adopt early; one of the clearest ROI use cases in B2B |
| Meeting transcription and summary | Low | High | Adopt freely; immediate time saving with no buyer-facing risk |
| Account research briefings | Low | Very high | Adopt early; dramatically improves sales conversation quality |
| Ad copy and creative variations | Medium — requires human curation | High | Use AI to generate options; human selects and refines |
| Personalised outbound emails | High if generic; medium if well-prompted | High | Use AI for first draft; significant human editing required for credibility |
| Competitive intelligence monitoring | Low | High | Adopt freely; automates a high-value but time-consuming task |
| Thought leadership and POV content | Very high — originality is the point | Low | Human only; AI assistance for research only, not drafting |
| RFP and proposal drafting | Medium — depends on buyer sophistication | Very high | Use AI for structure and boilerplate; human writes differentiated sections |
B2B buyers at enterprise level are increasingly sophisticated at identifying AI-generated content. A thought leadership article that reads like a language model wrote it damages the author's credibility more than not publishing the article at all. The bar for buyer-facing content is higher in B2B than in B2C because the relationship is closer and the stakes per deal are larger.
Calculate the real adoption cost before committing
The subscription fee for an AI tool is rarely the largest cost of adoption. The real costs are hidden in integration time, team training, ongoing management, and — critically — the editorial and quality assurance work required to ensure AI output meets buyer-facing standards.
If an AI tool requires more than 70% of the time it saves in management and editorial work, the net gain is not worth the organisational disruption of adoption. This threshold eliminates most AI content generation tools for senior B2B marketers — the editing required to make generic output credible takes most of the time the generation saved.
Build the minimum viable AI stack, not the maximum possible one
The instinct to adopt every impressive tool produces a fragmented stack that drains team time and produces inconsistent output. Build the minimum set of tools that address your highest-priority bottlenecks — and resist adding more until each tool is fully embedded and producing measurable results.
Marketing teams that adopt fewer tools but use them more deeply consistently outperform teams with larger stacks. Every tool added to the stack creates integration overhead, training requirements, and context-switching cost. The minimum viable stack is not a constraint — it is a competitive advantage.
Define the success metric before adopting — then measure it at 60 days
The final step of technology evaluation is pre-defining success. If you can't state in advance what the tool will improve and by how much, you are not ready to adopt it. If you haven't measured the result at 60 days, you have no basis for the next decision.
A marketing team that applies this framework consistently for 24 months will have evaluated 10-15 tools, kept 3-4, and built a small body of institutional knowledge about what works in their specific context. That knowledge is more valuable than any individual tool — and it is what allows them to adopt the next generation of technology faster and more accurately than competitors.
How companies across SaaS, IT services, manufacturing, and pharma have applied the evaluation framework — and what happened when they did or didn’t.
Gong's founding insight was that sales calls contained enormous signal that was being lost — no transcription, no analysis, no pattern recognition across conversations. The bottleneck was clear: sales managers had no visibility into what was actually happening in deals. The AI application (conversation intelligence, transcription, deal risk scoring) addressed that specific bottleneck directly. The credibility risk was low because the output was internal — it went to sales managers and revenue leaders, not to buyers. The ROI was measurable: deal win rate and sales cycle length. Gong applied the right framework to their own product design — which is also the framework their customers should apply when evaluating Gong.
A mid-sized Indian IT services firm targeting enterprise accounts in the US was losing deals in early discovery calls because sales reps were underprepared — they knew the company name but not the company's recent strategic initiatives, leadership changes, or publicly stated technology priorities. An AI tool was adopted specifically for this bottleneck: generating a 1-page account briefing from public sources before every significant sales conversation. Preparation time dropped from 45 minutes to 12 minutes per account. Conversation quality — measured through win rate at discovery stage — improved by 22% over two quarters. The credibility risk was zero because the output was internal. The evaluation framework was applied correctly: specific job, clear bottleneck, measurable outcome, low risk.
A B2B SaaS company targeting marketing operations professionals adopted an AI writing tool to increase blog output from four posts per month to twelve. Output volume tripled. Organic traffic increased modestly. SQL conversion from organic traffic fell by 35% over the same period. Exit surveys with prospects revealed that multiple buyers had noticed the content quality decline and cited it as a reason they were less confident in the company's expertise. The tool had passed the volume test and failed the credibility test — a test the team had not applied before adoption. The content programme was reduced back to four posts per month, all human-written, and SQL conversion rate recovered over the following quarter. The lesson: in B2B, content credibility is a pipeline asset. Scaling production by degrading quality is net negative even when traffic goes up.
An Indian precision components manufacturer adopted an AI-powered intent signal tool that monitored job postings, LinkedIn activity, and procurement forum discussions at target global accounts — flagging accounts showing signals of an upcoming sourcing decision. The tool identified five accounts in a six-month window that subsequently posted RFQs, three of which the company had never had prior contact with. The sales team made contact before the formal RFQ process, which gave them a significant advantage in the technical dialogue. The tool cost was recovered within the first closed deal. The application was low-risk (internal signal processing), high-value (early pipeline identification), and measurable (RFQ conversion rate from tool-identified accounts vs. cold outreach). A clean application of the evaluation framework.
A pharma B2B company whose marketing team needed to stay current on clinical publications relevant to their KOL network was spending 8 hours per week on manual literature monitoring. An AI tool was adopted to automate this: scanning PubMed and clinical journals for publications from or citing specific KOLs, flagging relevant new research, and generating a weekly digest. The tool reduced the monitoring time to under one hour per week and improved comprehensiveness — human monitoring had been missing 20-30% of relevant publications. The application was low-risk (internal research), high-value (better KOL intelligence), and immediately measurable (time savings and publication coverage rate). Medical affairs signed off on the adoption immediately because there was no patient-facing or promotional content risk.
List every AI or marketing technology tool currently active in your stack. For each one, write one sentence: what specific job does this tool do, and what metric tells you it is doing that job well? If you can't write that sentence for a tool, you don't have a clear enough reason to keep paying for it.
Then identify your single biggest marketing bottleneck — the one thing that, if removed, would most improve your pipeline quality or team capacity. That is the only thing worth evaluating a new tool against right now.
Every month, one hard B2B marketing problem.
First principles thinking. Real India context.
